FDA-cleared profile

BlineSlide

Deep Breathe, Inc. · Ultrasound · FDA-cleared (510(k))

Authorized purpose: Lung ultrasound cine processing for B-line artifact presence/absence detection.

Clinical role
Measurement/quantification support for physician-led lung ultrasound; results are not for sole patient-management decisions.
Images and patients
Ultrasound · Chest/Lung
Key limitation
Keep in mind: Incompatible with linear-array cines, less than 18 fps, more than 2048 MB, shorter than 2.6 seconds, or longer than 7.8 seconds. Cannot Evaluate outputs were scored as false predictions in FDA performance analysis; the device does not replace manual interpretation.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Lung ultrasound cine processing for B-line artifact presence/absence detection.
  • Which images or clinical context are in scope?Modality: Ultrasound Anatomy or clinical context: Chest/Lung Input: User-uploaded B-mode lung-ultrasound cines in MP4 format from anterior or anterolateral chest regions, acquired with non-linear-array transducers at at least 18 fps, 2.6-7.8 seconds duration, and no more than 2048 MB.
  • Who uses it?Intended users: Physicians credentialed to use lung ultrasound clinically, including intensivists, emergency physicians, pulmonologists, general practitioners, or other clinicians interpreting the source cines.
  • What does the software produce?Output: Presence or absence of B-line artifacts for each uploaded cine, displayed in a summary table; unsupported cines return Cannot Evaluate.
  • What is its most important limitation?Key limitation: Incompatible with linear-array cines, less than 18 fps, more than 2048 MB, shorter than 2.6 seconds, or longer than 7.8 seconds. Cannot Evaluate outputs were scored as false predictions in FDA performance analysis; the device does not replace manual interpretation.

Clinical takeaway. Clinical role: Lung ultrasound cine processing for B-line artifact presence/absence detection.

Evidence takeaway. Evidence from the reviewed source record: FDA standalone performance assessment used 1,005 cines from geographically distinct development and test sources; ground truth was consensus of at least two experts, with 25 poor-quality clips excluded and a final set of 326 B-line-present and 679 B-line-absent examples. Sensitivity and specificity were co-primary endpoints with Cannot Evaluate scored as false predictions: sensitivity 0.91 (95% CI 0.88-0.94) and specificity 0.84 (0.81-0.86). The FDA summary states clinical testing was not required for this device type.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Lung ultrasound cine processing for B-line artifact presence/absence detection.
  • Exact FDA submission
  • Checked 2026-09-08
Workflow role
Measurement/quantification support for physician-led lung ultrasound; results are not for sole patient-management decisions.
  • Exact FDA submission
  • Checked 2026-09-08
Required input
User-uploaded B-mode lung-ultrasound cines in MP4 format from anterior or anterolateral chest regions, acquired with non-linear-array transducers at at least 18 fps, 2.6-7.8 seconds duration, and no more than 2048 MB.
  • Exact FDA submission
  • Checked 2026-09-08
Output and clinician action
Presence or absence of B-line artifacts for each uploaded cine, displayed in a summary table; unsupported cines return Cannot Evaluate.
  • Exact FDA submission
  • Checked 2026-09-08
Care setting
Any setting where credentialed physicians perform lung ultrasound, including hospital, outpatient, remote, or austere environments.
  • Exact FDA submission
  • Checked 2026-09-08
Intended users
Physicians credentialed to use lung ultrasound clinically, including intensivists, emergency physicians, pulmonologists, general practitioners, or other clinicians interpreting the source cines.
  • Exact FDA submission
  • Checked 2026-09-08
Limitations
Incompatible with linear-array cines, less than 18 fps, more than 2048 MB, shorter than 2.6 seconds, or longer than 7.8 seconds. Cannot Evaluate outputs were scored as false predictions in FDA performance analysis; the device does not replace manual interpretation.
  • Exact FDA submission
  • Checked 2026-09-08
Evidence summary
FDA standalone performance assessment used 1,005 cines from geographically distinct development and test sources; ground truth was consensus of at least two experts, with 25 poor-quality clips excluded and a final set of 326 B-line-present and 679 B-line-absent examples. Sensitivity and specificity were co-primary endpoints with Cannot Evaluate scored as false predictions: sensitivity 0.91 (95% CI 0.88-0.94) and specificity 0.84 (0.81-0.86). The FDA summary states clinical testing was not required for this device type.
  • Exact FDA submission
  • Checked 2026-09-08

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
FDA standalone performance assessment used 1,005 cines from geographically distinct development and test sources; ground truth was consensus of at least two experts, with 25 poor-quality clips excluded and a final set of 326 B-line-present and 679 B-line-absent examples. Sensitivity and specificity were co-primary endpoints with Cannot Evaluate scored as false predictions: sensitivity 0.91 (95% CI 0.88-0.94) and specificity 0.84 (0.81-0.86). The FDA summary states clinical testing was not required for this device type.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Reported sensitivity
91% (95% CI: 88%, 94%)
  • Public source
  • Exact FDA submission
  • Checked 2026-09-01

Model sensitivity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.

Reported specificity
84% (95% CI: 81%, 86%)
  • Public source
  • Exact FDA submission
  • Checked 2026-09-01

Model specificity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

BlineSlide regulatory performance study summary

  • DesignStand-Alone Performance
  • PopulationAdult
  • Scopeexact submission
  • Tested versionExact product version not reported; regulatory study summarized for FDA submission K252007
  • Samplen=1005
  • IndependenceIndependence not established

K252007

ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K252007. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-08
Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: User-uploaded B-mode lung-ultrasound cines in MP4 format from anterior or anterolateral chest regions, acquired with non-linear-array transducers at at least 18 fps, 2.6-7.8 seconds duration, and no more than 2048 MB.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-08 · FDA K252007: BlineSlide

  2. Routing

    Source context, not route validation: Cloud service using user-uploaded MP4 cines; the FDA packet expressly says it does not directly interface with ultrasound systems and treats MP4 as DICOM-equivalent for this use. PACS, RIS, EHR, HL7, and FHIR integration are not established by the packet.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-08 · FDA K252007: BlineSlide

  3. AI processing

    Source context, not route validation: The exact FDA package describes Blineslide as a cloud service application that takes user-uploaded B-Mode lung ultrasound cines in MP4 format and does not directly interface with ultrasound systems. Current hosting, data flow, and commercial configuration require vendor confirmation.

    Scope: Exact FDA submission. Packet wording: "Blineslide is a cloud service application that helps qualified users with image-based assessment" … "It does not directly interface with ultrasound systems.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-11-14 · FDA K252007: BlineSlide

  4. Returned objects

    Source context, not route validation: Presence or absence of B-line artifacts for each uploaded cine, displayed in a summary table; unsupported cines return Cannot Evaluate.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-08 · FDA K252007: BlineSlide

  5. Viewer/worklist/report

    Unresolved route: Presence or absence of B-line artifacts for each uploaded cine, displayed in a summary table; unsupported cines return Cannot Evaluate.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-08 · FDA K252007: BlineSlide

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The exact FDA package describes Blineslide as a cloud service application that takes user-uploaded B-Mode lung ultrasound cines in MP4 format and does not directly interface with ultrasound systems. Current hosting, data flow, and commercial configuration require vendor confirmation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "Blineslide is a cloud service application that helps qualified users with image-based assessment" … "It does not directly interface with ultrasound systems.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

Integration
Cloud service using user-uploaded MP4 cines; the FDA packet expressly says it does not directly interface with ultrasound systems and treats MP4 as DICOM-equivalent for this use. PACS, RIS, EHR, HL7, and FHIR integration are not established by the packet.
  • Exact FDA submission
  • Checked 2026-09-08

ACR exact-submission catalog context

ACR AI Central provides an exact-submission model card for BlineSlide; FDA labeling remains controlling for clinical use, limitations, and performance.

exact submission · checked 2026-09-08
Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K252007
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
Ultrasound
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Anatomy
Chest/Lung
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2025-10-06
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-20Last searched
25Fields reviewed
9Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-09-08 - Exact FDA submission

    No public price or quote for the exact K252007 configuration was established in this review.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-09-08 - Exact FDA submission

    No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Security: Not verified - checked 2026-09-08 - Exact FDA submission

    Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.

  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-09-08 - Exact FDA submission

    Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

  • Monitoring: Not verified - checked 2026-09-08 - Exact FDA submission

    Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.

7 sources - 3 history items

Source ledger

  1. FDA K252007: BlineSlide

    U.S. Food and Drug Administration - Published 2025-10-06 - Accessed 2026-09-08

    Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation, deployment

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. BlineSlide model card (K252007)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: intendedUsers, careSetting, output, limitations, reportedSensitivity, reportedSpecificity, evidenceSummary, anatomy, evidenceStudies

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. openFDA exact recall query for K252007

    U.S. Food and Drug Administration - Accessed 2026-09-08

    Scope: postmarketSafety

Research history

  1. K252007 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K260234

MSK Go

Smart Alfa Teknoloji San. Ve Tic. A.S.

Authorized purpose: Assist qualified MSK-ultrasound professionals by highlighting supported joint anatomy and detection completeness on compatible adult ultrasound images; it is not a diagnostic device.

Modality
Ultrasound
Anatomy
Musculoskeletal joints: shoulder, elbow, wrist/hand, knee, and ankle/foot.
Decision
2026-05-21
FDA-cleared K252433

Sonio Detect (v3)

Sonio

Authorized purpose: Sonio Detect v3 analyzes fetal ultrasound images and clips to detect views and anatomical structures and to check labeled image-quality characteristics during acquisition or interpretation.

Modality
Ultrasound
Anatomy
Fetal anatomy
Decision
2026-03-16
FDA-cleared K250959

BioticsAI

Bioticsai, Inc.

Authorized purpose: BioticsAI assists healthcare professionals during and after fetal ultrasound acquisition and interpretation by detecting views and anatomical structures and facilitating quality-criteria verification on DICOM images and frames; it is a concurrent reading aid for the labeled GE ultrasound and prenatal population.

Modality
Ultrasound
Anatomy
Obstetric/Fetal
Decision
2025-12-22

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history